Prepared by the attorneys of BRACE Law Firm, this Life Sciences Regulatory Digest analyzes recent legislative and regulatory updates within the pharmaceutical sector, specifically focusing on:

1. The execution of critical regulatory instruments governing the circulation of medicinal products within the Eurasian Economic Union (EAEU).
2. Voluntary self-disclosures by pharmaceutical market participants regarding anticompetitive agreements, aimed at securing leniency or immunity from applicable antitrust sanctions.
3. Legislative amendments proposed by the Ministry of Industry and Trade of the Russian Federation to permit foreign drug manufacturers to apply for state registration of medicines without a Good Manufacturing Practice (GMP) certificate.

The digest further evaluates recent judicial and administrative precedents, drawing on both Russian and international enforcement landscapes.

For comprehensive insights into the legal shifts shaping the life sciences sector, please visit the “Pharmaceuticals and Law” web portal.